These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36082254)

  • 1. European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease.
    Psychogios M; Brehm A; López-Cancio E; Marco De Marchis G; Meseguer E; Katsanos AH; Kremer C; Sporns P; Zedde M; Kobayashi A; Caroff J; Bos D; Lémeret S; Lal A; Arenillas JF
    Eur Stroke J; 2022 Sep; 7(3):III-IV. PubMed ID: 36082254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Stroke Organisation (ESO) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on acute management of basilar artery occlusion.
    Strbian D; Tsivgoulis G; Ospel J; Räty S; Cimflova P; Georgiopoulos G; Ullberg T; Arquizan C; Gralla J; Zelenak K; Hussain S; Fiehler J; Michel P; Turc G; van Zwam WH
    J Neurointerv Surg; 2024 Aug; 16(9):e7. PubMed ID: 39043395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update.
    Schirmer CM; Bulsara KR; Al-Mufti F; Haranhalli N; Thibault L; Hetts SW;
    J Neurointerv Surg; 2023 Nov; 15(11):1155-1162. PubMed ID: 37188504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Stroke Organisation and European Society for Minimally Invasive Neurological Therapy guideline on acute management of basilar artery occlusion.
    Strbian D; Tsivgoulis G; Ospel J; Räty S; Cimflova P; Georgiopoulos G; Ullberg T; Arquizan C; Gralla J; Zeleňák K; Hussain S; Fiehler J; Michel P; Turc G; Van Zwam W
    Eur Stroke J; 2024 Dec; 9(4):835-884. PubMed ID: 38752743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular Treatment for Acute Large Vessel Occlusion Due to Underlying Intracranial Atherosclerotic Disease.
    Huo X; Sun D; Chen W; Han H; Abdalkader M; Puetz V; Yi T; Wang H; Liu R; Tong X; Jia B; Ma N; Gao F; Mo D; Yan B; Mitchell PJ; Leung TW; Yavagal DR; Albers GW; Costalat V; Fiehler J; Zaidat OO; Jovin TG; Liebeskind DS; Nguyen TN; Miao Z
    Semin Neurol; 2023 Jun; 43(3):337-344. PubMed ID: 37549690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESO guideline for the management of extracranial and intracranial artery dissection.
    Debette S; Mazighi M; Bijlenga P; Pezzini A; Koga M; Bersano A; Kõrv J; Haemmerli J; Canavero I; Tekiela P; Miwa K; J Seiffge D; Schilling S; Lal A; Arnold M; Markus HS; Engelter ST; Majersik JJ
    Eur Stroke J; 2021 Sep; 6(3):XXXIX-LXXXVIII. PubMed ID: 34746432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2023 Taiwan Stroke Society Guidelines for the management of patients with intracranial atherosclerotic disease.
    Lin CJ; Chung CP; Liao NC; Chen PL; Chi NF; Lai YJ; Tang CW; Wu CH; Chang FC; Luo CB; Fay LY; Lin CF; Chou CH; Lee TH; Lee JT; Jeng JS; Lee IH;
    J Chin Med Assoc; 2023 Aug; 86(8):697-714. PubMed ID: 37341526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study.
    Dumont TM; Sonig A; Mokin M; Eller JL; Sorkin GC; Snyder KV; Hopkins LN; Levy EI; Siddiqui AH
    J Neurosurg; 2016 Oct; 125(4):964-971. PubMed ID: 26745485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results.
    Qureshi AI; Feldmann E; Gomez CR; Johnston SC; Kasner SE; Quick DC; Rasmussen PA; Suri MF; Taylor RA; Zaidat OO
    J Neuroimaging; 2009 Oct; 19 Suppl 1():1S-10S. PubMed ID: 19807850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular treatment of symptomatic intracranial atherosclerotic disease.
    Short JL; Majid A; Hussain SI
    Front Neurol; 2011; 1():160. PubMed ID: 21359195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It.
    Mekonnen EA; Tekle WG; Desai SK; Hassan AE
    Interv Neuroradiol; 2023 Aug; 29(4):459-465. PubMed ID: 35331035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging agents for the treatment and prevention of stroke: progress in clinical trials.
    Safouris A; Magoufis G; Tsivgoulis G
    Expert Opin Investig Drugs; 2021 Oct; 30(10):1025-1035. PubMed ID: 34555978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular treatment of acute ischemic stroke with a fully radiopaque retriever: A randomized controlled trial.
    Zhang Y; Liu P; Li Z; Peng Y; Chen W; Zhang L; Chu J; Kuai D; Chen Z; Wu W; Xu Y; Zhang Y; Zhou B; Geng Y; Yin C; Li J; Wang M; Zhai N; Peng X; Ji Z; Xiao Y; Zhu X; Cai X; Zhang L; Hong B; Xing P; Shen H; Zhang Y; Li M; Shang M; Liu J; Yang P
    Front Neurol; 2022; 13():962987. PubMed ID: 36588884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, diagnosis and management of intracranial atherosclerotic disease.
    Jeng JS; Tang SC; Liu HM
    Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1423-32. PubMed ID: 20936929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Advances in Endovascular Treatment of Intracranial Atherosclerotic Disease and Future Prospective.
    Jafari M; Nguyen TN; Ortega-Gutierrez S; Hussain MS; Hassan AE; Ikram A; Eliyas JK; Rodriguez GJ; Divani AA
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105556. PubMed ID: 33360252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2C19 Loss-of-Function is Associated with Increased Risk of Ischemic Stroke after Transient Ischemic Attack in Intracranial Atherosclerotic Disease.
    Patel PD; Vimalathas P; Niu X; Shannon CN; Denny JC; Peterson JF; Chitale RV; Fusco MR
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105464. PubMed ID: 33246208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large Vessel Occlusion Stroke due to Intracranial Atherosclerotic Disease: Identification, Medical and Interventional Treatment, and Outcomes.
    de Havenon A; Zaidat OO; Amin-Hanjani S; Nguyen TN; Bangad A; Abbasi M; Anadani M; Almallouhi E; Chatterjee R; Mazighi M; Mistry EA; Yaghi S; Derdeyn CP; Hong KS; Kvernland A; Leslie-Mazwi TM; Al Kasab S
    Stroke; 2023 Jun; 54(6):1695-1705. PubMed ID: 36938708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
    Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA
    J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy.
    Kass-Hout T; Morsi RZ; Thind S; Karrison T; Lee H; Nahab F; Gupta R; Carrión-Penagos J; Awad IA; Coleman E; Brorson JR; McKoy C; Morales J; Mendelson S; Mansour A; Prabhakaran S
    J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107227. PubMed ID: 37437522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.